JPRN-UMIN000049814尚未招募Unknown
Evaluation of efficacy of the community pharmacy intervention to optimize serum potassium levels in patients with chronic kidney disease - Investigating the efficacy of community pharmacy intervention on serum potassium levels in patients with chronic kidney disease
ational Hospital Organization Mie Chuo Medical Center0 个研究点目标入组 40 人开始时间: 2022年12月18日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients who do not agree to participate in this study 2) Patients with communication difficulties 3) Patients with hypokalemia (serum potassium level less than 4.0 mmol/L) 4) Patients on maintenance dialysis 5) Patients who bring refill prescriptions 6) Patients taking oral potassium preparations 7) Patients who are not expected to continuously visit the insurance pharmacy under study for at least 3 months
研究者
相似试验
已完成
不适用
Evaluation of the use of a patient questionnaire in measuring patient reported outcomes of medication reviewsadverse drug reactions (ADRs), side effects of drugs, medication adherence (MARS), beliefs about medicines necessity and concerns (BMQ), self efficacy (MUSE)NL-OMON28732Radboud university medical center, Radboud Institute for Health Sciences, IQ Healthcare, Nijmegen, The Netherlands200
招募中
不适用
Increasing Community Pharmacy Involvement in the Prevention of Cardiovascular Disease ProjectACTRN12609000705280Monash450
尚未招募
不适用
Evaluating the feasibility and acceptability of the MedsCheck Plus service amongst community pharmacists and home-dwelling people living with dementiaDementiaACTRN12622001172796niversity of New South Wales (UNSW)25
已完成
不适用
Assessment of community pharmacies' support for smoking cessation treatment in collaboration with medical institutionsSmoking cessationJPRN-UMIN000044380School of Pharmacy, Nihon University70
进行中（未招募）
不适用
A community pharmacy based investigation in the self-medication areaEfficacy and safety of Sinutab® [Paracetamol (500mg) and Pseudoephedrine (30mg)] on subjects with nasal congestion accompanied by headache in the setting of a common coldThe medical rationale = to investigate this combination drug in the symptomatic relief of common cold with nasal symptoms. The reduction of symptom severity may allow subjects receiving active medication to return to work or school earlier than those receiving placebo. To study the drug in it’s ‘natural environment’, community pharmacists will function as local investigators. They will include subjects with early (= 48 hours) cold symptoms of blocked nose with headache.EUCTR2006-000058-35-BEPfizer Consumer Healthcare Comm. VA/SCA